A substance being studied in the treatment of certain types of cancer, including non-Hodgkin lymphoma, breast, colon, lung, ovarian, and prostate. Enzastaurin hydrochloride blocks certain cell signaling pathways, and may prevent the growth of new blood vessels needed for tumors to grow. It is a type of serine threonine kinase inhibitor. Also called enzastaurin and LY317615.